<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27442631</article-id>
      <article-id pub-id-type="pmc">5265748</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000003932</article-id>
      <article-id pub-id-type="art-access-id">03932</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>4900</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case report of isolated lymphadenopathy revealing localized leishmanial lymphadenopathy in an asthenic 25-year-old man</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hurlot</surname>
            <given-names>Quentin</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fillaux</surname>
            <given-names>Judith</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Laurent</surname>
            <given-names>Camille</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Berry</surname>
            <given-names>Antoine</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hofman</surname>
            <given-names>Paul</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff4">
            <sup>d</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marchou</surname>
            <given-names>Bruno</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff5">
            <sup>e</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Delobel</surname>
            <given-names>Pierre</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>e</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brousset</surname>
            <given-names>Pierre</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff6">
            <sup>f</sup>
          </xref>
          <xref ref-type="aff" rid="aff7">
            <sup>g</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martin-Blondel</surname>
            <given-names>Guillaume</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>e</sup>
          </xref>
          <xref>
            <sup>&#x2217;</sup>
          </xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Siddiqi.</surname>
            <given-names>Haseeb</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Department of Pathology, Institut Universitaire du Cancer</aff>
      <aff id="aff2"><label>b</label>Department of Parasitology, Toulouse University Hospital</aff>
      <aff id="aff3"><label>c</label>INSERM, Centre de Physiopathologie Toulouse-Purpan, Toulouse</aff>
      <aff id="aff4"><label>d</label>Department of Pathology, Nice University Hospital, Nice</aff>
      <aff id="aff5"><label>e</label>Department of Infectious and Tropical Diseases, Toulouse University Hospital</aff>
      <aff id="aff6"><label>f</label>CRCT INSERM U1037, Toulouse</aff>
      <aff id="aff7"><label>g</label>Laboratoire d&#x2019;Excellence Toulouse Cancer LABEX-TOUCAN, France.</aff>
      <author-notes id="cor1">
        <corresp><label>&#x2217;</label>Correspondence: Guillaume Martin-Blondel, Department of Infectious and Tropical Diseases, Toulouse University Hospital, Place du Docteur Baylac TSA 40031, 31059 Toulouse cedex 9, France (e-mail: <email>martin-blondel.g@chu-toulouse.fr</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>29</issue>
      <elocation-id>e3932</elocation-id>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>5</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e3932.pdf"/>
      <abstract>
        <title>Abstract</title>
        <sec sec-type="background">
          <title>Background:</title>
          <p>Visceral leishmaniasis (VL) is endemic in large areas of the tropics, the subtropics, and the Mediterranean basin. Besides classical VL presentation, exceptional cases of a limited form of VL have been reported. Here we describe the challenges of diagnosis and management of this intriguing entity.</p>
        </sec>
        <sec>
          <title>Case summary:</title>
          <p>A 25-year-old French Caucasian man presented with marked asthenia that had lasted 6 months and was strictly isolated except for a 2-cm left cervical lymphadenopathy. The rest of the clinical examination and extensive biological exploration were unremarkable.</p>
          <p>Histological examination of the cervical lymphadenopathy showed a reactive lymphoid hyperplasia with granulomatous organization associated with small particles in the cytoplasm of epithelioid histiocytes and giant cells evocative of Leishman&#x2013;Donovan bodies. Polymerase chain reaction (PCR) performed on the tissue confirmed the presence of <italic>Leishmania donovani/infantum</italic> DNA. Direct examination of a bone marrow aspiration, together with blood and bone marrow PCR, did not find other evidence for VL. Serology for leishmaniasis was unreactive. Extensive work-up for other causes of granulomatous lymphadenitis was negative. A diagnosis of localized leishmanial lymphadenopathy was made. Intravenous liposomal amphotericin B (20&#x200A;mg/kg in five infusions) was initiated and well tolerated. Asthenia disappeared promptly and the patient fully recovered.</p>
        </sec>
        <sec sec-type="conclusion">
          <title>Conclusion:</title>
          <p>Localized lymph node enlargement because of leishmanial infection should be included in the differential diagnosis of lymphadenopathy of unknown origin in patients who stayed or visited, even a long time ago and for a short period, endemic areas for leishmaniasis such as the Mediterranean basin. Fine-needle aspiration cytology and/or PCR for <italic>Leishmania sp</italic> of the lymphadenopathy might contribute to the diagnosis. A low-dose liposomal amphotericin B treatment might be effective, and deserves further study.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>amphotericin B</kwd>
        <kwd>diagnosis</kwd>
        <kwd>leishmaniasis</kwd>
        <kwd>lymphadenopathy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Visceral leishmaniasis (VL) is a zoonotic vector-borne disease caused by the <italic>Leishmania donovani</italic> protozoa complex <italic>(L donovani and Leishmania infantum</italic>).<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> VL is endemic in large areas of the tropics, subtropics, and the Mediterranean basin and can occur in travelers coming back from affected countries. The complex parasite&#x2013;host interactions that predispose some individuals to developing the disease or to controlling the infection influence a spectrum of clinical manifestations ranging from asymptomatic to fatal visceral infections.<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> Here we report an unusual case of VL presenting as an isolated cervical lymphadenopathy in an immunocompetent host.</p>
    </sec>
    <sec>
      <label>2</label>
      <title>Case presentation</title>
      <p>A 25-year-old French Caucasian man presented in December 2014 with marked asthenia that had lasted 6 months. He had no fever, weight loss, or night sweats and was asymptomatic except for this profound asthenia. He had no past medical history. This patient was born and lived in Paris, France, and had moved 2 years before Toulouse, in the southwestern part of France. He traveled to Egypt for 1 week in 2009, spent 1 month in China and Vietnam in July 2013, and 2 weeks in Corsica in September 2013. The clinical examination was unremarkable except for a firm and mobile 2&#x200A;cm left cervical lymphadenopathy without inflammatory signs. In particular, he had no other lymphadenopathy, nor any hepatosplenomegaly, and the otorhinolaryngology examination was normal. Laboratory blood tests showed normal cell count, creatinine, C-reactive protein, hepatic enzyme, and lactate dehydrogenase levels. Erythrocyte sedimentation rate, as well as serum protein electrophoresis, was normal. Serologies for human immunodeficiency virus (HIV), syphilis, and <italic>Bartonella henselae</italic> were unreactive. Serology for toxoplasmosis showed IgG without IgM. A computed tomography scan of the neck, chest, abdomen, and pelvis showed no other lymphadenopathy, and no evidence for sarcoidosis, tuberculosis, or cancer. The cervical lymphadenopathy was biopsied. The histologic examination of the lymphadenopathy revealed a reactive lymphoid hyperplasia with granulomatous organization. Hematoxylin and eosin (Fig. <xref ref-type="fig" rid="F1">1</xref>A), <italic>Periodic Acid&#x2013;Schiff</italic> and Grocott (not shown) colorations showed small particles in the cytoplasm of epithelioid histiocytes and giant cells evocative of Leishman&#x2013;Donovan bodies. Polymerase chain reaction (PCR) performed on the biopsy confirmed the presence of <italic>L donovani/infantum</italic> DNA<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> and was negative for <italic>Toxoplasma gondii</italic>. Immunohistochemistry using a monoclonal antibody p19&#x2013;11 raised against the <italic>Leishmania</italic> homologue of receptors for activated C-kinase was also positive (diluted 1:80,<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup>Fig. <xref ref-type="fig" rid="F1">1</xref>B). Immunohistochemistry for <italic>T gondii</italic> (<italic>T gondii</italic> Ab-1 Rabbit polyclonal antibody) and HIV (anti-HIV-1 p24 antibody), and in situ hybridization for Epstein&#x2013;Barr virus-encoded RNA, were negative. Direct examination of a bone marrow aspiration, together with blood and bone marrow PCR, did not find other evidence for VL. Serology for leishmaniasis was unreactive by <italic>indirect fluorescent assay</italic> (<italic>vircell leishmania indirect fluorescent antibody IgG L infantum</italic>) and immunochromatography (BioRad-IT Leish &#x201C;<italic>L infantum</italic>&#x201D;), but homemade <italic>L infantum</italic>-specific Western blot showed 14- and 18-kDa bands.<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> Extensive work-up for other causes of granulomatous lymphadenitis, including PCR in blood, stool, and saliva for <italic>Tropheryma whipplei</italic>, was negative. A diagnosis of localized leishmanial lymphadenopathy was made. Intravenous liposomal amphotericin B (20&#x200A;mg/kg in 5 infusions) was initiated and well tolerated. Asthenia disappeared promptly and the patient fully recovered.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Histopathology of the cervical lymphadenopathy. (A) Hematoxylin and eosin coloration (magnification &#xD7;1000) of the lymphadenopathy showing granulomatous organization with giant cells and epithelioid histiocytes. Arrows show Leishman&#x2013;Donovan bodies. (B) Immunohistochemistry of the lymphadenopathy using a monoclonal anti-Leishman antibody (magnification &#xD7;1200), demonstrating leishmanial parasites with their nuclei (arrows).</p>
        </caption>
        <graphic xlink:href="medi-95-e3932-g001"/>
      </fig>
    </sec>
    <sec>
      <label>3</label>
      <title>Discussion</title>
      <p>After being transmitted by the bite of phlebotomine sand flies, leishmanial amastigotes disseminate through the lymphatic and vascular systems and infect the reticulo-endothelial system, resulting in infiltration of the bone marrow, liver, spleen, and lymph nodes.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> Approximately 0.2 to 0.4 million new VL cases occur each year, with an overall case fatality rate of 10%. The most common presentation of VL includes signs of persistent systemic infection (high-grade fever, asthenia, anorexia, and weight loss) and of parasitic invasion of the blood and reticulo-endothelial system (lymphadenopathy, hepatomegaly, splenomegaly, pancytopenia, and hypergammaglobulinemia). VL symptoms often persist for several weeks to months before patients either seek medical care or die from bacterial co-infections, massive bleeding, or severe anemia. Liposomal amphoterin B is used as first-line treatment in Europe and the United States.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> However, asymptomatic infections are far more frequent than symptomatic VL cases in immunocompetent hosts, demonstrating that many people infected with visceral leishmanial species develop an effective immune response and do not manifest the clinical disease.<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup> In between, rare cases of a limited form of VL presenting as isolated lymphadenopathy without other evidence of VL have been described as localized leishmanial lymphadenopathy.<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup> The clinical presentation of this emerging entity has been recently defined in 17 consecutive patients presenting with localized leishmanial lymphadenopathy during a large outbreak of <italic>L infantum</italic> VL that occurred in Spain.<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> Localized leishmanial lymphadenopathy exclusively affects immunocompetent hosts. As in the case described here, patients presented with indolent lymphadenopathy affecting mainly the cervical area (65%) without fever or systemic symptoms. Diagnosis can be made by fine-needle aspiration cytology of the lymphadenopathy, showing granulomatous lymphadenitis with leishmanial parasites. PCR for <italic>L donovani/infantum</italic> DNA on aspiration might also be a useful tool. Serological testing was not reliable, as half of the patients in this study had negative results. Although no consensus on therapeutic management of localized leishmanial lymphadenopathy has been formulated,<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> patients were usually treated for VL. Regarding that form of the disease, in the Spanish study, 2 patients displayed lymphadenopathies affecting different areas, and 1 had clinical and biological signs evocative of early stages of typical VL, suggesting that localized leishmanial lymphadenopathy might evolve toward a systemic disease.<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> However, treatments received were heterogeneous, and liposomal amphoterin B was used, with total dose varying from 10 to 30&#x200A;mg/kg. Overall, the outcome was favorable, regardless of the dose used. Because patients suffering from localized leishmanial lymphadenopathy are not immunocompromised and the disease is still limited to the lymph node, the use of lower total doses of liposomal amphoterin B (10&#x200A;mg/kg) has been advocated.</p>
    </sec>
    <sec>
      <label>4</label>
      <title>Conclusion</title>
      <p>Localized lymph node enlargement because of leishmanial infection should be included in the differential diagnosis of lymphadenopathy of unknown origin in patients who stayed or visited, even a long time ago, endemic areas for leishmaniasis such as the Mediterranean basin (Table <xref ref-type="table" rid="T1">1</xref>). Fine-needle aspiration cytology and/or PCR for <italic>Leishmania sp</italic> of the lymphadenopathy might contribute to the diagnosis. A low-dose liposomal amphotericin B treatment might be effective and deserves further study.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Main causes of localized lymphadenopathy (enlargement of a single node or multiple contiguous nodal regions, adapted from<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup>).</p>
        </caption>
        <graphic xlink:href="medi-95-e3932-g002"/>
      </table-wrap>
    </sec>
    <sec>
      <title>Acknowledgments</title>
      <p>The authors would like to thank David and Virginia Clark for their kind help in English editing.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: HIV = human immunodeficiency virus, PCR = polymerase chain reaction, VL = visceral leishmaniasis.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chappuis</surname><given-names>F</given-names></name><name><surname>Sundar</surname><given-names>S</given-names></name><name><surname>Hailu</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?</article-title>
<source><italic>Nat Rev Microbiol</italic></source>
<year>2007</year>; <volume>5</volume>:<fpage>873</fpage>&#x2013;<lpage>882</lpage>.<pub-id pub-id-type="pmid">17938629</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCall</surname><given-names>LI</given-names></name><name><surname>Zhang</surname><given-names>WW</given-names></name><name><surname>Matlashewski</surname><given-names>G</given-names></name></person-group>
<article-title>Determinants for the development of visceral leishmaniasis disease</article-title>. <source><italic>PLoS Pathog</italic></source>
<year>2013</year>; <volume>9</volume>:<fpage>e1003053</fpage>.<pub-id pub-id-type="pmid">23300451</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavergne</surname><given-names>RA</given-names></name><name><surname>Iriart</surname><given-names>X</given-names></name><name><surname>Martin-Blondel</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Contribution of molecular diagnosis to the management of cutaneous leishmaniasis in travellers</article-title>. <source><italic>Clin Microbiol Infect</italic></source>
<year>2014</year>; <volume>20</volume>:<fpage>O528</fpage>&#x2013;<lpage>O530</lpage>.<pub-id pub-id-type="pmid">24279601</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mougneau</surname><given-names>E</given-names></name><name><surname>Altare</surname><given-names>F</given-names></name><name><surname>Wakil</surname><given-names>AE</given-names></name><etal/></person-group>
<article-title>Expression cloning of a protective Leishmania antigen</article-title>. <source><italic>Science</italic></source>
<year>1995</year>; <volume>268</volume>:<fpage>563</fpage>&#x2013;<lpage>566</lpage>.<pub-id pub-id-type="pmid">7725103</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marty</surname><given-names>P</given-names></name><name><surname>Lelievre</surname><given-names>A</given-names></name><name><surname>Quaranta</surname><given-names>JF</given-names></name><etal/></person-group>
<article-title>Detection by Western blot of four antigens characterizing acute clinical leishmaniasis due to <italic>Leishmania infantum</italic></article-title>. <source><italic>Trans R Soc Trop Med Hyg</italic></source>
<year>1995</year>; <volume>89</volume>:<fpage>690</fpage>&#x2013;<lpage>691</lpage>.<pub-id pub-id-type="pmid">8594698</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="book"><collab>WHO</collab>. <source>Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22&#x2013;26 March 2010&#x2014;</source>
<comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/handle/10665/44412">http://apps.who.int/iris/handle/10665/44412</ext-link> - sthash.VOzUfdWM.dpuf: World Health Organization; 2010. Accessed July 5, 2016</comment>.</mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moral</surname><given-names>L</given-names></name><name><surname>Rubio</surname><given-names>EM</given-names></name><name><surname>Moya</surname><given-names>M</given-names></name></person-group>
<article-title>A leishmanin skin test survey in the human population of l&#x2019;Alacanti region (Spain): implications for the epidemiology of <italic>Leishmania infantum</italic> infection in southern Europe</article-title>. <source><italic>Trans R Soc Trop Med Hyg</italic></source>
<year>2002</year>; <volume>96</volume>:<fpage>129</fpage>&#x2013;<lpage>132</lpage>.<pub-id pub-id-type="pmid">12055798</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomares-Estran</surname><given-names>C</given-names></name><name><surname>Cenderello</surname><given-names>G</given-names></name><name><surname>Ittel</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Isolated lymphadenopathy in <italic>Leishmania infantum</italic> infection: three case reports</article-title>. <source><italic>Ann Trop Med Parasitol</italic></source>
<year>2009</year>; <volume>103</volume>:<fpage>555</fpage>&#x2013;<lpage>559</lpage>.<pub-id pub-id-type="pmid">19695161</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horrillo</surname><given-names>L</given-names></name><name><surname>San Martin</surname><given-names>JV</given-names></name><name><surname>Molina</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Atypical presentation in adults in the largest community outbreak of leishmaniasis in Europe (Fuenlabrada, Spain)</article-title>. <source><italic>Clin Microbiol Infect</italic></source>
<year>2015</year>; <volume>21</volume>:<fpage>269</fpage>&#x2013;<lpage>273</lpage>.<pub-id pub-id-type="pmid">25658537</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>AK</given-names></name><name><surname>Davies</surname><given-names>HD</given-names></name></person-group>
<article-title>Cervical lymphadenitis: etiology, diagnosis, and management</article-title>. <source><italic>Curr Infect Dis Rep</italic></source>
<year>2009</year>; <volume>11</volume>:<fpage>183</fpage>&#x2013;<lpage>189</lpage>.<pub-id pub-id-type="pmid">19366560</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
